BioMed Research International

BioMed Research International / 2015 / Article
Special Issue

Newly Emerging Parasitic Threats for Human Health: National and International Trends

View this Special Issue

Research Article | Open Access

Volume 2015 |Article ID 728321 |

Monika Dybicz, Piotr Karol Borkowski, Julia Dąbrowska, Lidia Chomicz, "Cases of Echinococcus granulosus Sensu Stricto Isolated from Polish Patients: Imported or Indigenous?", BioMed Research International, vol. 2015, Article ID 728321, 5 pages, 2015.

Cases of Echinococcus granulosus Sensu Stricto Isolated from Polish Patients: Imported or Indigenous?

Academic Editor: Stefano D’Amelio
Received30 Jun 2015
Revised21 Aug 2015
Accepted16 Sep 2015
Published30 Sep 2015


The cases of nine Polish patients with diagnosed cystic echinococcosis (CE) were examined. A total of nine isolates obtained postoperatively were investigated using PCR and sequencing. The mitochondrial region of nad1 gene was amplified. This PCR and sequencing analysis revealed the presence of Echinococcus canadensis G7 in seven patients and E. granulosus G1 in two patients. These data demonstrate that E. canadensis is the predominant causative agent of human cystic echinococcosis in Poland. E. granulosus G1 detection in Polish patients suggests that the parasite was imported; however it does not exclude the possibility that these cases could have been of Polish origin.

1. Introduction

Cystic echinococcosis (CE) is caused by the metacestode stage of the Echinococcus granulosus complex belonging to the family Taeniidae. CE is considered as one of the most important zoonotic parasitic diseases worldwide. The life cycle of Echinococcus species is mostly domestic, involving dogs as the definitive host, in which the adult worm lives in the small intestine. Wild canids (dingoes, wolves, jackals, coyotes, red foxes, etc.) can also serve as definitive hosts in the transmission cycle. The hydatid cyst metacestode develops in the internal organs of an intermediate host that acquires the infection through accidental ingestion of the tapeworm eggs. The intermediate hosts can be sheep, goats, swine, cattle, and humans. The cysts in humans develop mainly in the liver (70%), lungs (20%), and other organs like the brain, heart, and bones [1]. The cysts usually may develop asymptomatically for years and clinical symptoms occur when the cysts press on the surrounding tissues or organs. CE can be life-threatening when the cysts rupture into the peritoneal cavity causing anaphylaxis or can cause secondary CE. Echinococcosis is regarded as an emerging disease occurring worldwide with the highest prevalence in parts of Eurasia, north and east Africa, Australia, and South America [26].

Analysis of mitochondrial and nuclear genes of different Echinococcus species has led to taxonomic revisions and the genotypes G1–G3 are now grouped as E. granulosus sensu stricto, G4 is as Echinococcus equinus, G5 is as Echinococcus ortleppi, G6–G10 are as Echinococcus canadensis, and the “lion strain” is as Echinococcus felidis [711]. Among these strains, E. granulosus sensu stricto has a broad geographical distribution with a wide host range and is the major causative agent of human cystic echinococcosis.

In Poland, identified CE human cases have not been common; 260 patients have been treated in the Department of Zoonoses and Tropical Diseases within 10 years. The main Echinococcus strain, detected in Polish domesticated animals (pigs, dogs), is E. canadensis (G7) [12]. Molecular studies of the cysts isolated from humans revealed the presence of the G7 genotype [12, 13]. E. canadensis G7 strain has also been identified in humans in Ukraine [12], the Slovak Republic [12, 14], Turkey [15], and Austria [16]. Recently the first human cases of G7 infection in Mongolia [17], South Africa [18], and China [19] were found.

In our report we aim to characterize species of Echinococcus causing CE among cases of patients who underwent surgery to remove a cyst.

2. Materials and Methods

2.1. Materials

Fragments of cysts were collected from 9 patients postoperatively, carried out between January 2010 and May 2015 in the Department of Zoonoses and Tropical Diseases of the Medical University of Warsaw, Poland. Some patients treated with albendazole due to having cystic echinococcosis have been under medical supervision for many years. On account of some complications the cysts were removed surgically. The patient data collected included age, gender, and city. Six patients were females and three were males. The age of the patients ranged from 26 to 77 years. The examined samples represented by part of a cyst were stored frozen at −20°C or fixed in 70% ethanol prior to molecular analysis.

2.2. DNA Extraction and PCR

The samples of examined isolates and E. canadensis G7 positive control (isolates JX266793 and JX266824) were rinsed with phosphate-buffered saline (PBS) several times to remove any ethanol and centrifuged at 5000 ×g for 10 min. Each pellet was dissolved in 100 μL PBS and genomic DNA was extracted using a NucleoSpin kit (Macherey-Nagel, Düren, Germany) following the manufacturer’s instructions. Two mitochondrial regions were amplified by PCR using the prepared DNAs as templates. Part of the NADH dehydrogenase 1 (nad1) gene was amplified using primers JB11 (5′-AGATTCGTAAGGGGCCTAATA-3′) and JB12 (5′-ACCACTAACTAATTCACTTTC-3′) [20]. The 50 μL reactions were comprised of 1 μL of DNA template, 50 pM of each primer, 0.2 mM of each dNTP, 1x PCR buffer containing 2.5 mM MgCl2, and 1 U of Taq DNA polymerase (Qiagen, Hilden, Germany). The following PCR was performed in a PTC-200 thermal cycler (MJ Research, Waltham, USA) in conditions: 3 min at 95°C followed by 35 cycles of 1 min at 95°C, 1 min at 50°C, and 1 min at 72°C. The PCR products were separated by electrophoresis on a 2% agarose gel (MetaPhor, FMC BioProducts, Philadelphia, USA) and then stained with ethidium bromide and observed on a UV transilluminator. The nad1 gene fragments were purified and then directly sequenced in both directions using a BigDye Ready Reaction Cycle Sequencing kit and an ABI 3730 Genetic Analyzer (Applied Biosystems, Foster City, USA). Chromatograms were manually checked and edited using Chromas 2.0. The obtained sequences were aligned with others retrieved from NCBI GenBank using ClustalW2 (

3. Results

A total of 9 samples were obtained from patients who underwent surgery to remove a cyst located in the liver (6 cases of women and 2 men) and in the hip muscle (1 case of a man). The patients came mostly from Warsaw, other cities and villages of central Poland, where they lived in either urban (40%) or rural areas (60%), and most of them had close contact with dogs. Eight patients suffered from primary and one patient from secondary cystic echinococcosis. The majority of the cysts ranged in size from 3 to 7 cm in diameter, and the largest one was 9 cm; 6 out of 9 cases were active (mostly type CE2), whereas the remaining cysts were sterile (type CE3) (Table 1). DNA extracted from all 9 samples and positive controls were used as the template in separate PCRs to amplify region of the mitochondrial NADH dehydrogenase 1. Each PCR produced a single band upon agarose gel electrophoresis. All isolates and controls were diagnosed as positive by amplification of nad1 fragment (~500 bp). The nad1 fragments were sequenced and compared with sequences of Echinococcus genotypes available in NCBI GenBank. The sequences of 7 isolates showed 100% identity to that of the pig strain G7, designated E. canadensis (Table 1). The sequences of 2 other isolates were identical to the sheep strain E. granulosus G1 (Table 1). All nad1 sequences were deposited in GenBank with accession numbers KT780293–KT780301.

Case numberCity/regionAge in years, sexDiagnosis detailsSpecies

1Warsaw (central Poland)55
Liver single cyst (~6 cm), type CE2, removed with albendazole administration.E. canadensis G7

2Central Poland77
Liver single cyst (3.5 cm), type CE2, removed with albendazole administration.E. canadensis G7

3Central Poland48
Three cysts in the liver (size 5–7 cm), type CE2, removed with albendazole administration.E. canadensis G7

4Warsaw (central Poland)31
Single liver cyst (~5 cm), type CE3, treated with albendazole for months and then removed.
ELISA and Western blot positive.
E. canadensis G7

5Ostrołęka (northeast of central Poland)26
Single liver cyst (~9 cm), type CE2.
When bleeding occurred, the cyst was removed with albendazole administration.
E. canadensis G7

6Warsaw (central Poland)28
Single cyst (6.5 cm), type CE2 with two cysts inside (1.4 and 2.2 cm), located at the surface of liver, not treated pharmacologically, Western blot positive.
When severe abdominal pain occurred, cyst was removed. Patient spent one week in Turkey 2 years before CE was diagnosed.
E. granulosus G1

7Central Poland53
Single liver cyst (~5 cm), type CE3, removed with albendazole administration.E. canadensis G7

8Warsaw (central Poland)60
Three cysts (each ~4 cm) in the hip muscle, type CE2.
The cysts were detected during CT scan of colon cancer diagnosis and then removed. In 2001, the primary cyst from hip muscle was removed in Kazakhstan.
E. granulosus G1

9Central Poland48
Single liver cyst, removed with albendazole administration.E. canadensis G7

4. Discussion

E. granulosus sensu lato is a complex of genetic variants with genotypic and phenotypic differences such as intermediate host specificity or development. Recent molecular studies on the taxonomy of E. granulosus sensu lato have revealed that it is a complex of five independent species [711]. The genetic identification has been significant in understanding the transmission of the parasite between definitive and intermediate hosts, including humans. The cosmopolitan strain of E. granulosus is the G1 (sheep) genotype distributed worldwide and occurring particularly in areas of extensive sheep farming. It is the predominant strain infecting humans, but the other genotypes are also known to be infective. The presence of other Echinococcus strains in humans has been confirmed in Argentina, Kenya, Egypt (G1, G2, G5, and G6), Poland, Ukraine, the Slovak Republic, Turkey, Austria, South Africa (G7), Russia, and Mongolia (G10) [1218, 2125]. Transmission of E. canadensis G7 is considered to be restricted to certain areas in central, southern, and eastern Europe, Spain, Poland, Lithuania, the Slovak Republic, Ukraine, Romania, and Italy [1216, 2630], where the most common intermediate host is the pig. Recently, E. canadensis G7 has also been identified in pigs from Mexico and Brazil [3133]. It has often been assumed that Echinococcus strains isolated from pigs of European origin are a separate strain and have low infectivity for humans and domestic ungulates [34]. Genetic investigations based on nad1 sequence alignment showed the presence of E. canadensis G7 in Polish patients [12, 13], although another pig strain identified in human was designated G9, closely related to G6 (based on its1 region analysis) and to G7 (nad1 sequence analysis) [35].

In this report, we used PCR and sequencing to characterize Echinococcus cysts isolated from the liver and hip muscle of patients who underwent surgery to remove the cyst during the period of the last 5 years. In this analysis samples from 9 patients were examined. The patients were diagnosed as having cystic echinococcosis, following histopathological examination, imaging techniques, and/or immunological tests. Most of these patients have been under medical supervision for many years and treated with albendazole for months and due to some complications (bleeding inwards, detachment of internal capsule, and strong abdominal pain) it was decided that the cyst should be removed. Of these 9 samples, we were able to diagnose 7 cases as liver CE caused by E. canadensis, predictably as it was described already in a group of 30 patients in Poland [13].

The nad1 sequences from 7 samples corresponded to the E. canadensis G7 strain. Taking into consideration the fact that E. canadensis G7 has already been confirmed in Poland and pigs are the major intermediate host, the G7 strain plays a significant role being the aetiological agent of human cystic echinococcosis in Poland. Interestingly, 2 other samples were identical to E. granulosus G1. This is the first report revealing E. granulosus sensu stricto hydatids isolated from humans carried out in Poland. These isolates involved a female and a male. The female patient (case number 6) with diagnosed CE of the liver, resembling sheep strain in computer tomography, was treated with albendazole. The cyst had two daughter cysts and after albendazole treatment, detachment of the capsule and parasite death were observed. A year later the patient suffered from very strong abdominal pain and the deceased hydatid was surgically excised. In the interview with the patient it was denoted that she travelled to Turkey a few years ago and spent a week there before CE was diagnosed, suggesting possibility of infection with G1 strain abroad. The Polish male patient (case number 8) was operated on in 2001 in Kazakhstan on account of the cyst found in the muscle of the left hip but the diagnosis of CE was not confirmed by histopathological or any other study. At present, after resettlement to Poland, colon cancer has been diagnosed and during routine tomography small cysts have been localized in the left hip muscle. The tumor and the cysts were removed and sent for confirmation. The preliminary identification of E. granulosus G1 in this case, considering the patient’s history, implies the case has been imported from Kazakhstan where G1 strain is predominant. This fact does not exclude the possibility of infection of different hosts by E. granulosus G1 or other strains in Poland. The knowledge of the distribution of Echinococcus genetic variants in all parts of the country has not been ascertained yet.

Genotypes E. granulosus G1 and E. canadensis G7 are morphologically and genetically different; however both can develop in humans and pigs, generating threats to the public health and the animal breeding. Therefore, it is necessary to examine the pathology and etiology of CE based on molecular identification to assess the genotype. Still many aspects remain inadequately determined such as the factors establishing host specificity and developmental diversity among different strains of Echinococcus.

5. Conclusion

Cystic echinococcosis is an important zoonotic emerging disease occurring worldwide which is caused by the hydatid cyst metacestode stage of different Echinococcus species. In Poland, human CE is considered to be rather infrequent and mainly induced by the G7 pig strain of E. canadensis. In this report we identified E. canadensis G7 in seven human liver cysts; however in two cases (liver and hip muscle) the hydatids were diagnosed as E. granulosus G1. As it follows, E. canadensis has been the predominant strain in Poland, but revealing G1 strain in two patients remains unclear if these have been imported cases or maybe indigenous ones.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors sincerely thank Professor Bruce Conn for linguistic assistance and valuable comments on the present work.


  1. Z. S. Pawlowski, J. Eckert, D. A. Vuitton et al., “Echinococcosis in humans: clinical aspects, diagnosis and treatment,” in WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern, J. Eckert, M. A. Gemmell, F. X. Meslin, and Z. S. Pawlowski, Eds., pp. 20–66, World Organisation for Animal Health, Paris, France, 2001. View at: Google Scholar
  2. A. Ito, C. Urbani, Q. Jiamin et al., “Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China,” Acta Tropica, vol. 86, no. 1, pp. 3–17, 2003. View at: Publisher Site | Google Scholar
  3. D. J. Jenkins, T. Romig, and R. C. A. Thompson, “Emergence/re-emergence of Echinococcus spp.—a global update,” International Journal for Parasitology, vol. 35, no. 11-12, pp. 1205–1219, 2005. View at: Publisher Site | Google Scholar
  4. P. Moro and P. M. Schantz, “Cystic echinococcosis in the Americas,” Parasitology International, vol. 55, supplement, pp. S181–S186, 2006. View at: Publisher Site | Google Scholar
  5. T. Romig, A. Dinkel, and U. Mackenstedt, “The present situation of echinococcosis in Europe,” Parasitology International, vol. 55, supplement, pp. S187–S191, 2006. View at: Publisher Site | Google Scholar
  6. A. Seimenis, “Overview of the epidemiological situation on echinococcosis in the Mediterranean region,” Acta Tropica, vol. 85, no. 2, pp. 191–195, 2003. View at: Publisher Site | Google Scholar
  7. M. Nakao, D. P. McManus, P. M. Schantz, P. S. Craig, and A. Ito, “A molecular phylogeny of the genus Echinococcus inferred from complete mitochondrial genomes,” Parasitology, vol. 134, no. 5, pp. 713–722, 2007. View at: Publisher Site | Google Scholar
  8. M. Nakao, T. Yanagida, M. Okamoto et al., “State-of-the-art Echinococcus and Taenia: phylogenetic taxonomy of human-pathogenic tapeworms and its application to molecular diagnosis,” Infection, Genetics and Evolution, vol. 10, no. 4, pp. 444–452, 2010. View at: Publisher Site | Google Scholar
  9. R. C. A. Thompson, “The taxonomy, phylogeny and transmission of Echinococcus,” Experimental Parasitology, vol. 119, no. 4, pp. 439–446, 2008. View at: Publisher Site | Google Scholar
  10. U. Saarma, I. Jõgisalu, E. Moks et al., “A novel phylogeny for the genus Echinococcus, based on nuclear data, challenges relationships based on mitochondrial evidence,” Parasitology, vol. 136, no. 3, pp. 317–328, 2009. View at: Publisher Site | Google Scholar
  11. C. A. Alvarez Rojas, T. Romig, and M. W. Lightowlers, “Echinococcus granulosus sensu lato genotypes infecting humans—review of current knowledge,” International Journal for Parasitology, vol. 44, no. 1, pp. 9–18, 2014. View at: Publisher Site | Google Scholar
  12. A. H. Kȩdra, Z. Swiderski, V. V. Tkach et al., “Genetic analysis of Echinococcus granulosus from humans and pigs in Poland, Slovakia and Ukraine,” Acta Parasitologica, vol. 44, no. 4, pp. 248–254, 1999. View at: Google Scholar
  13. M. Dybicz, A. Gierczak, J. Dabrowska, Ł. Rdzanek, and B. Michałowicz, “Molecular diagnosis of cystic echinococcosis in humans from central Poland,” Parasitology International, vol. 62, no. 4, pp. 364–367, 2013. View at: Publisher Site | Google Scholar
  14. L. Turčeková, V. Šnábel, S. D'Amelio, M. Busi, and P. Dubinský, “Morphological and genetic characterization of Echinococcus granulosus in the Slovak Republic,” Acta Tropica, vol. 85, no. 2, pp. 223–229, 2003. View at: Publisher Site | Google Scholar
  15. V. Šnábel, N. Altintas, S. D'Amelio et al., “Cystic echinococcosis in Turkey: genetic variability and first record of the pig strain (G7) in the country,” Parasitology Research, vol. 105, no. 1, pp. 145–154, 2009. View at: Publisher Site | Google Scholar
  16. R. Schneider, B. Gollackner, M. Schindl, G. Tucek, and H. Auer, “Echinococcus canadensis G7 (pig strain): an underestimated cause of Cystic Echinococcosis in Austria,” The American Journal of Tropical Medicine and Hygiene, vol. 82, no. 5, pp. 871–874, 2010. View at: Publisher Site | Google Scholar
  17. A. Jabbar, M. Narankhajid, M. J. Nolan, A. R. Jex, B. E. Campbell, and R. B. Gasser, “A first insight into the genotypes of Echinococcus granulosus from humans in Mongolia,” Molecular and Cellular Probes, vol. 25, no. 1, pp. 49–54, 2011. View at: Publisher Site | Google Scholar
  18. B. K. Mogoye, C. N. Menezes, M. L. Wong et al., “First insights into species and genotypes of Echinococcus in South Africa,” Veterinary Parasitology, vol. 196, no. 3-4, pp. 427–432, 2013. View at: Publisher Site | Google Scholar
  19. T. Zhang, D. Yang, Z. Zeng et al., “Genetic characterization of human-derived hydatid cysts of Echinococcus granulosus sensu lato in Heilongjiang Province and the first report of G7 genotype of E. canadensis in humans in China,” PLoS ONE, vol. 9, no. 10, Article ID e109059, 2014. View at: Publisher Site | Google Scholar
  20. J. Bowles and D. P. McManus, “NADH dehydrogenase 1 gene sequences compared for species and strains of the genus Echinococcus,” International Journal for Parasitology, vol. 23, no. 7, pp. 969–972, 1993. View at: Publisher Site | Google Scholar
  21. H. E. Abdel Aaty, D. M. Abdel-Hameed, Y. H. Alam-Eldin et al., “Molecular genotyping of Echinococcus granulosus in animal and human isolates from Egypt,” Acta Tropica, vol. 121, no. 2, pp. 125–128, 2012. View at: Publisher Site | Google Scholar
  22. A. Casulli, E. Zeyhle, E. Brunetti et al., “Molecular evidence of the camel strain (G6 genotype) of Echinococcus granulosus in humans from Turkana, Kenya,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 104, no. 1, pp. 29–32, 2010. View at: Publisher Site | Google Scholar
  23. E. A. Guarnera, A. Parra, L. Kamenetzky, G. García, and A. Gutiérrez, “Cystic echinococcosis in Argentina: evolution of metacestode and clinical expression in various Echinococcus granulosus strains,” Acta Tropica, vol. 92, no. 2, pp. 153–159, 2004. View at: Publisher Site | Google Scholar
  24. S. V. Konyaev, T. Yanagida, M. Nakao et al., “Genetic diversity of Echinococcus spp. in Russia,” Parasitology, vol. 140, no. 13, pp. 1637–1647, 2013. View at: Publisher Site | Google Scholar
  25. A. Ito, T. Dorjsuren, A. Davaasuren et al., “Cystic Echinococcoses in mongolia: molecular identification, serology and risk factors,” PLoS Neglected Tropical Diseases, vol. 8, no. 6, article e2937, 2014. View at: Publisher Site | Google Scholar
  26. J. M. Bart, S. Morariu, J. Knapp et al., “Genetic typing of Echinococcus granulosus in Romania,” Parasitology Research, vol. 98, no. 2, pp. 130–137, 2006. View at: Publisher Site | Google Scholar
  27. R. Bružinskaite, M. Šarkunas, P. R. Torgerson, A. Mathis, and P. Deplazes, “Echinococcosis in pigs and intestinal infection with Echinococcus spp. in dogs in southwestern Lithuania,” Veterinary Parasitology, vol. 160, no. 3-4, pp. 237–241, 2009. View at: Publisher Site | Google Scholar
  28. L. M. González, K. Daniel-Mwambete, E. Montero et al., “Further molecular discrimination of Spanish strains of Echinococcus granulosus,” Experimental Parasitology, vol. 102, no. 1, pp. 46–56, 2002. View at: Publisher Site | Google Scholar
  29. V. Šnábel, S. D'Amelio, K. Mathiopoulos, L. Turčeková, and P. Dubinský, “Molecular evidence for the presence of a G7 genotype of Echinococcus granulosus in Slovakia,” Journal of Helminthology, vol. 74, no. 2, pp. 177–181, 2000. View at: Google Scholar
  30. A. Varcasia, S. Canu, M. W. Lightowlers, A. Scala, and G. Garippa, “Molecular characterization of Echinococcus granulosus strains in Sardinia,” Parasitology Research, vol. 98, no. 3, pp. 273–277, 2006. View at: Publisher Site | Google Scholar
  31. N. Villalobos, L. M. González, J. Morales et al., “Molecular identification of Echinococcus granulosus genotypes (G1 and G7) isolated from pigs in Mexico,” Veterinary Parasitology, vol. 147, no. 1-2, pp. 185–189, 2007. View at: Publisher Site | Google Scholar
  32. D. U. Monteiro, S. A. Botton, A. A. Tonin et al., “Echinococcus canadensis (G7) and Echinococcus granulosus sensu stricto (G1) in swine of southern Brazil,” Veterinary Parasitology, vol. 202, no. 3-4, pp. 335–338, 2014. View at: Publisher Site | Google Scholar
  33. U. Rodriguez-Prado, D. E. Jimenez-Gonzalez, G. Avila et al., “Short report: genetic variation of Echinococcus canadensis (G7) in Mexico,” American Journal of Tropical Medicine and Hygiene, vol. 91, no. 6, pp. 1149–1153, 2014. View at: Publisher Site | Google Scholar
  34. Z. Pawłowski and J. Stefaniak, “The pig strain of Echinococcus granulosus in humans: a neglected issue?” Trends in Parasitology, vol. 19, no. 10, p. 439, 2003. View at: Publisher Site | Google Scholar
  35. J. C. Scott, J. Stefaniak, Z. S. Pawłowski, and D. P. McManus, “Molecular genetic analysis of human cystic hydatid cases from Poland: identification of a new genotypic group (G9) of Echinococcus granulosus,” Parasitology, vol. 114, no. 1, pp. 37–43, 1997. View at: Publisher Site | Google Scholar

Copyright © 2015 Monika Dybicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.